1. Evidence for a Tumour Suppressive Function of APRG1 in Breast Cancer

   • A.C.A. Leris
   • T.R. Roberts
   • K. Mokbel

   Report Pages: 97 - 100

2. RhoC-GTPase is a Novel Tissue Biomarker Associated with Biologically Aggressive Carcinomas of the Breast

   • Celina G. Kleer
   • Kent A. Griffith
   • Sofia D. Merajver

   Report Pages: 101 - 110

3. The Presence of Serum Anti-p53 Antibodies from Patients with Invasive Ductal Carcinoma of Breast: Correlation to Other Clinical and Biological Parameters

   • Rui-juan Gao
   • Hui-zheng Bao
   • Li Wang

   Report Pages: 111 - 115

4. Timely Withdrawal of G-CSF Reduces the Occurrence of Thrombocytopenia During Dose-dense Chemotherapy

   • J.N.H. Timmer-Bonte
   • P.H.M. de Mulder
   • V.C.G. Tjan-Heijnen

   Clinical trial Pages: 117 - 123

5. A Multicenter Randomized Clinical Trial Evaluating Interleukin-2 Activated Hematopoietic Stem Cell Transplantation and Post-transplant IL-2 for High Risk Breast Cancer Patients

   • Claudine Isaacs
   • Rebecca Slack
   • Marc Lippman

   Clinical Trial Pages: 125 - 134

6. The role of X-linked genes in breast cancer

   • Archana Thakur
   • Hiaming Xu
   • Joshua D. Liao

   Report Pages: 135 - 143

7. Incidence of Male Breast Cancer in California, 1988–2000: Racial/Ethnic Variation in 1759 Men

   • Cynthia O’Malley
   • Sarah Shema
   • Sally Glaser

   Report Pages: 145 - 150

8. Patterns of Local and Distant Disease Relapse in Patients with Breast Cancer Treated with Primary Chemotherapy: Do Patients with a Complete Pathological Response Differ from Those with Residual Tumour in the Breast?

   • Shailesh Chaturvedi
   • Catherine McLaren
   • Steven D. Heys

   Report Pages: 151 - 158

9. Multiple Signaling Pathways are Activated During Insulin-like Growth Factor-I (IGF-I) Stimulated Breast Cancer Cell Migration

   • Xihong Zhang
   • Min Lin
   • Douglas Yee

   Report Pages: 159 - 168

10. Innate Anti-breast Cancer Immunity of Apoptosis-resistant Human γδ-T cells

    • Ben L. Guo
    • Zhiyong Liu
    • Richard D. Lopez

    Report Pages: 169 - 175

11. Inhibition of Either Phosphatidylinositol 3-kinase/Akt or the Mitogen/Extracellular-regulated Kinase, MEK/ERK, Signaling Pathways Suppress Growth of Breast Cancer Cell Lines, but MEK/ERK Signaling is Critical for Cell Survival

    • Maureen O. Ripple
    • Sahana Kalmadi
    • Alan Eastman

    Report Pages: 177 - 188